ArticleOncology2022

Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Atsushi Hiraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.